All In Biotech

Drug Trial Radar · NCT07091630

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Sep 16, 2025

Primary completion

Oct 7, 2027

Study completion Jan 23, 2031

Sponsor

Lead sponsor
argenxargenx (ARGX)
Sponsor type
Industry
First posted
Jul 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or placebo for 24 weeks (6 months). Following part A, participants will enter part B in which all participants will receive empasiprubart for 96 weeks (24 months). More information can be found here: https://clinicaltrials.argenx.com/emnergize

Conditions

  • Chronic Inflammatory Demyelinating Polyneuropathy
  • CIDP
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Interventions

  • Empasiprubart IVBiological

    Intravenous infusion of empasiprubart

  • Placebo IVOther

    Intravenous infusion of placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction of ≥1 point compared with baseline in aINCAT score at week 24Time frame: Up to 24 weeks

Locations

95 sites in 25 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham - 1720 University Blvd

    Birmingham, Alabama · Recruiting

  • Banner University of Arizona Medical Center

    Tucson, Arizona · Recruiting

  • Samir Macwan, M.D., Inc. (S corporation)

    Rancho Mirage, California · Recruiting

  • Colorado Springs Neurological Associates

    Colorado Springs, Colorado · Recruiting

  • Medstar Health Research Institute

    Washington D.C., District of Columbia · Recruiting

  • Gables Neurology

    Miami, Florida · Recruiting

  • Aqualane Clinical Research

    Naples, Florida · Recruiting

  • Vero Beach Neurology and Research Institute

    Vero Beach, Florida · Recruiting

  • Paradigm Health System

    Slidell, Louisiana · Recruiting

  • Penn Medicine University City

    Philadelphia, Pennsylvania · Recruiting

  • Jefferson Health Honickman Center

    Philadelphia, Pennsylvania · Recruiting

  • University Neurology

    Knoxville, Tennessee · Recruiting

  • National Neuromuscular Research Institute

    Austin, Texas · Recruiting

  • NeuroCarePlus

    Houston, Texas · Recruiting

  • Instituto Privado Kremer

    Córdoba, Argentina · Recruiting

  • Instituto Médico de la Fundación Estudios Clínicos

    Rosario, Argentina · Recruiting

  • INECO Neurociencias Oroño

    Rosario, Argentina · Recruiting

  • Universitätsklinikum AKH Wien

    Vienna, Austria · Recruiting

  • Kepler Universitätsklinikum Linz - Med Campus III

    Linz, Upper Austria, Austria · Recruiting

  • L2 Ip - Instituto de Pesquisas Clinicas Ltda - ME

    Brasília, Brazil · Recruiting

  • Hospital Moinhos de Vento

    Porto Alegre, Brazil · Recruiting

  • PSEG Centro de Pesquisa Clinica

    São Paulo, Brazil · Recruiting

  • Escola Bahiana de Medicina e Saude Publica

    Salvador, Estado de Bahia, Brazil · Recruiting

  • Unidade de Pesquisa Clinica e Inovacao da Estacio

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

  • Hospital de Clinicas de Porto Alegre (HCPA) - PPDS

    Pôrto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • Hospital Das Clinicas da Faculdade de Medicina de Ribeirao Preto - UPS - PPDS

    Ribeirão Preto, São Paulo, Brazil · Recruiting

  • University Multiprofile Hospital for Active Treatment

    Pleven, Bulgaria · Recruiting

  • Medical Center Medika 2005 - Branch Sofia

    Sofia, Bulgaria · Recruiting

  • University Multiprofile Hospital for Active Treatment Aleksandrovska EAD

    Sofia, Bulgaria · Recruiting

  • University Multiprofile Hospital for Active Treatment and Emergency Medicine N. I. Pirogov EAD

    Sofia, Bulgaria · Recruiting

  • Multiprofile Hospital for Active Treatment of Neurology and Psychiatry Sv. Naum EAD

    Sofia, Sofia, Bulgaria · Recruiting

  • Peking University First Hospital - Changqiao Campus

    Beijing, China · Recruiting

  • Guangdong Provincial Hospital of Chinese Medicine

    Guangzhou, China · Recruiting

  • Nanfang Hospital Southern Medical University

    Guangzhou, China · Recruiting

  • Guangzhou First People's Hospital

    Guanzhou, China · Recruiting

  • The Second Affiliated Hospital of Nanchang University (Donghu Campus)

    Nanchang, China · Recruiting

  • The First Affiliated Hospital of Soochow University

    Suzhou, China · Recruiting

  • Xi'an Gaoxin Hospital

    Xi'an, China · Recruiting

  • Fujian Medical University Union Hospital - Yushan Campus

    Fuzhou, Fujian, China · Recruiting

  • The People's Hospital of Baiyun District Guangzhou

    Guangzhou, Guangdong, China · Recruiting

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.